Advancement of Nalbuphine ER Through Clinical Development in Multiple Indications New Haven, CT, August 12, 2019– Trevi Therapeutics, Inc. (Nasdaq: […]
Integration will benefit customers with increased inventory availability and expanded offerings in the Southeast HURST, TX August 1,
NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on
Two powerhouses in the bridge infrastructure and engineering space come together to provide customers with a wider spectrum of premium
TSM is poised to continue its strong growth in heat exchange and thermal management products March 4, 2019 – Wilton,
Event in Nairobi gathered more than 350 international leaders in trade and export finance (Parsippany, New Jersey) – 24 April
